<p>Siiltibcy is used to help detect infection and disease caused by <em>Mycobacterium tuberculosis</em> in adults and children aged 4 weeks and older.</p><p>Siiltibcy contains the active substances rdESAT-6 and rCFP-10, two proteins from the <em>M. tuberculosis</em> bacterium. </p>
Therapeutic Indication
<div class="subsection mt-3-5"> <h3>Therapeutic indication</h3><p>Diagnosis of infection with Mycobacterium tuberculosis.</p></div>
Therapeutic Area (MeSH)
ATC Code
V04CF
ATC Item
N/A
Pharmacotherapeutic Group
Tuberculosis diagnostics
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| Mycobacterium tuberculosis derived antigens (rdESAT‑6 and rCFP‑10) | N/A | Mycobacterium tuberculosis derived antigens (rdESAT‑6 and rCFP‑10) |
EMA Name
Siiltibcy
Medicine Name
Siiltibcy
Aliases
N/ANo risk management plan link.
